2017
DOI: 10.1007/s11010-017-3025-x
|View full text |Cite
|
Sign up to set email alerts
|

Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway

Abstract: Hyperoside is a major active constituent in many medicinal plants traditionally used in Chinese medicines for their anti-inflammatory, antioxidative, and vascular protective effects. Recent studies have focused on the protective effects of hyperoside on hyperlipidemia. However, the molecular mechanisms underlying these effects are unknown. In this study, vascular smooth muscle cells (VSMCs) were treated in vitro with oxidized low-density lipoprotein (oxLDL) in the presence or absence of hyperoside. Western blo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 24 publications
2
14
0
Order By: Relevance
“…Next, inhibition of MEK by PD98095 cancelled the activation of ERK induced by OxLDL ( Figure 4 D). Lectin-like OxLDL receptor-1 (LOX-1) was identified as a major receptor for the uptake of OxLDL [ 9 ] and activation of ERK pathway was shown to be mediated by LOX-1 [ 28 ]. In our study, the expression of LOX-1 was significantly increased in INS-1 cells ( Figure 4 E), suggesting that OxLDL suppressed ABCA1 transcription via LOX-1/MEK/ERK pathway in INS-1 cells.…”
Section: Resultsmentioning
confidence: 99%
“…Next, inhibition of MEK by PD98095 cancelled the activation of ERK induced by OxLDL ( Figure 4 D). Lectin-like OxLDL receptor-1 (LOX-1) was identified as a major receptor for the uptake of OxLDL [ 9 ] and activation of ERK pathway was shown to be mediated by LOX-1 [ 28 ]. In our study, the expression of LOX-1 was significantly increased in INS-1 cells ( Figure 4 E), suggesting that OxLDL suppressed ABCA1 transcription via LOX-1/MEK/ERK pathway in INS-1 cells.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, ERK1/2 was shown to be activated by ox-LDL in vascular smooth muscle cells and endothelial cells via LOX-1 [6668]. Inhibition of ERK suppressed cell proliferation in ox-LDL-treated vascular smooth muscle cells [66, 67] and reduced matrix metalloproteinase expression in endothelial cells [68]. These results suggest that the LOX-1/ERK axis may serve as a potential therapeutic target for LDL(-)-mediated atherosclerosis.…”
Section: Discussionmentioning
confidence: 99%
“…The C-type lectin domain is critical for oxLDL binding. In terms of expression, LOX-1 is ubiquitously expressed in vascular cells, such as endothelial cells (Sawamura et al, 1997), macrophages (Draude et al, 1999), VSMCs (Zhang et al, 2017), cardiomyocytes (Schlüter et al, 2017), and fibroblasts (Liu et al, 2016a). The ubiquitous expression pattern of LOX-1 in cardiovascular cells implicates its important role in regulating cardiovascular pathophysiology.…”
Section: A Cholesterol Uptakementioning
confidence: 99%